Antibody News and Research

RSS
An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Further Reading

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

16 Dec 2022
Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections

Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections

16 Dec 2022
SARS-CoV-2 Omicron BQ and XBB subvariants show exceptional immune evasion properties

SARS-CoV-2 Omicron BQ and XBB subvariants show exceptional immune evasion properties

16 Dec 2022
Scientists identify a novel epitope at the SARS-CoV-2 spike furin cleavage site

Scientists identify a novel epitope at the SARS-CoV-2 spike furin cleavage site

15 Dec 2022
New immunosensor could be a fast, inexpensive, and convenient tool to detect COVID-19

New immunosensor could be a fast, inexpensive, and convenient tool to detect COVID-19

15 Dec 2022
How do predicted ecological niches of the mpox virus compare with that of 99 mammal species?

How do predicted ecological niches of the mpox virus compare with that of 99 mammal species?

15 Dec 2022
Sheep milk could be an inexpensive source of therapeutic polyclonal SARS-CoV-2 neutralizing antibodies

Sheep milk could be an inexpensive source of therapeutic polyclonal SARS-CoV-2 neutralizing antibodies

15 Dec 2022
Study identifies Δ42PD-1 as novel therapeutic target for hepatocellular carcinoma immunotherapy

Study identifies Δ42PD-1 as novel therapeutic target for hepatocellular carcinoma immunotherapy

15 Dec 2022
Randomized trials demonstrate the safety of Ebola vaccine regimens in adults and children

Randomized trials demonstrate the safety of Ebola vaccine regimens in adults and children

15 Dec 2022
Study assesses COVID-19 booster vaccination coverage by demographics and behaviors and experiences toward vaccination among fully vaccinated adults

Study assesses COVID-19 booster vaccination coverage by demographics and behaviors and experiences toward vaccination among fully vaccinated adults

15 Dec 2022
‘Cocktail’ vaccines could offer protection against current and future SARS-CoV-2 'variants of concern'

‘Cocktail’ vaccines could offer protection against current and future SARS-CoV-2 'variants of concern'

15 Dec 2022
Novel experimental system traces the development and longevity of plasma cells

Novel experimental system traces the development and longevity of plasma cells

15 Dec 2022
The implications of pulmonary tissue-resident memory T lymphocytes in COVID-19 and other respiratory diseases

The implications of pulmonary tissue-resident memory T lymphocytes in COVID-19 and other respiratory diseases

14 Dec 2022
Study indicates need for developing mucosal vaccines to induce potent immune responses at sites where SARS-CoV-2 infection occurs

Study indicates need for developing mucosal vaccines to induce potent immune responses at sites where SARS-CoV-2 infection occurs

14 Dec 2022
Characterization of immune evasion and cell entry for new variants: BQ.1.1, XBB.1, and BR.2.1

Characterization of immune evasion and cell entry for new variants: BQ.1.1, XBB.1, and BR.2.1

13 Dec 2022
Obesity and type 2 diabetes impair mRNA COVID vaccine efficacy in mouse model

Obesity and type 2 diabetes impair mRNA COVID vaccine efficacy in mouse model

13 Dec 2022
Researchers identify molecular determinants of post-infection long-COVID

Researchers identify molecular determinants of post-infection long-COVID

13 Dec 2022
Overview of current methods, technologies, and applications in the molecular diagnosis of mpox

Overview of current methods, technologies, and applications in the molecular diagnosis of mpox

13 Dec 2022
Study finds bebtelovimab therapy lacks efficacy in patients infected with SARS-CoV-2 Omicron subvariants

Study finds bebtelovimab therapy lacks efficacy in patients infected with SARS-CoV-2 Omicron subvariants

13 Dec 2022
Targeted therapies and novel drug combinations show promise for the treatment of multiple leukemias

Targeted therapies and novel drug combinations show promise for the treatment of multiple leukemias

13 Dec 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback